Quote this valuation with its source: Fair value, Potential value and the price at analysis.
FAQ
AXON — frequently asked questions
Is Axon Enterprise Inc. overvalued?
In our latest published analysis dated 2026-10-03, AXON looks meaningfully overvalued. The price recorded at analysis is USD 413 versus our fair value of USD 219; the high endpoint is presented separately as potential value of USD 345. That implies roughly 47.0% downside to fair value at that date.
Our latest published report, analyzed 2026-10-03, gives AXON a fair value of USD 219 and a potential value of USD 345. The conclusion is triangulated across multiple valuation models and weighted by reliability for Axon Enterprise Inc.'s archetype; it is a dated research output, not a live price.
Should I buy AXON now?
Our latest published rating for AXON, analyzed 2026-10-03, is Sell. Axon Enterprise Inc. looks meaningfully overvalued at the analysis-date price of USD 413 versus fair value of USD 219; potential value is USD 345. This is research for educational purposes, not personalized investment advice.
What are the biggest risks for AXON?
The dedicated bear-case section in our report analyzed 2026-10-03 documents Axon Enterprise Inc.'s material risks, evidence, thresholds, and thesis-invalidation conditions. Scenario-specific explanations remain in that section so the report does not repeat or decontextualize them elsewhere.
What is AXON's rating?
Our latest published rating for AXON, analyzed 2026-10-03, is Sell, with a published moat assessment of 7.5/10 (Narrow). It reflects our fair value of USD 219, the potential value of USD 345, and the price recorded at analysis (USD 413).
Accelerated adoption of Evidence.com cloud software modules and AI-enabled drafting across state, local, and international agencies, driving Software and Sensors revenue (which reached $1,202.67M in FY2025) beyond 50% of net sales, unlocking substantial operating leverage as manufacturing capital expenditures ($136.26M in FY2025) normalize toward steady-state levels.
We assign a Sell rating to Axon Enterprise Inc. While Axon commands a defensible narrow competitive moat through its integrated hardware and Evidence.com software ecosystem, the current valuation of 58.14x forward earnings leaves no margin of safety against persistent stock-based compensationdilution ($634.23M in FY2025) and extended municipal budget procurement cycles.4,8
At the current trading price of $413.35 as of October 2, 2026, Axon Enterprise Inc. This multiple reflects a substantial premium over traditional aerospace and defense peers such as L3Harris at 17.48x and TransDigm at 22.57x. While Axon's software platform characteristics support a valuation premium over defense contractors, the current stock price implies aggressive multi-year earnings compounding that discounts little operational friction or multiple mean-reversion.3,4
The primary driver of our Sell rating is the pronounced divergence between Axon's GAAP operating profitability and its elevated equity valuation. For FY2025, Axon recorded GAAP revenue of $2,779.54M and gross profit of $1,658.13M (59.65% gross margin), yet generated a GAAP operating loss of -$62.08M (-2.23% operating margin). Operating losses were heavily driven by $634.23M in stock-based compensation, which absorbed 22.82% of net revenue. While non-GAAP adjustments add back this expense, equity dilution has expanded diluted shares from 75.46M in FY2023 to 82.37M in FY2025, siphoning substantial economic value away from per-share compounding.8
Capital expenditure intensity has also constrained realized cash conversion across recent periods. Capital expenditures rose from $59.64M in FY2023 to $78.79M in FY2024 and peaked at $136.26M in FY2025 (1.64x annual depreciation of $83.16M) as Axon built automated manufacturing tooling for TASER 10. This capital cycle limited FY2025 free cash flow to $75.08M despite operating cash flow of $211.34M. Although Q2 2026 capex moderated to $21.05M ($22.95M YTD) and management targets $450M in full-year free cash flow, sustaining this cash flow pace requires frictionless municipal budget conversion.5,6,7,8
Axon continues to possess structural competitive strengths supporting a narrow economic moat (score 7.5), anchored by high customer switching costs in Evidence.com and strong officer mindshare. Software and Sensors revenue reached $1,202.67M in FY2025 (43.27% of net sales), while Connected Devices contributed $1,576.86M. In Q2 2026, 5-year normalized bookings expanded over 30%, Outpost and Lightpost rolling 12-month bookings reached ~$100M, and agencies canceled competitor contracts early to switch to Axon. However, with non-US revenue representing only 17.07% of sales ($474.52M in FY2025), international expansion face regulatory hurdles. Given the extreme valuation premium, we advise reducing exposure.5,9
Evidence.com Cloud Platform Workflow Lock-In
Software and Sensors revenue reached $1,202.67M in FY2025 (43.27% of net sales), generating high gross margins (59.65% consolidated) and deep workflow lock-in as public safety agencies rely on Evidence.com for evidentiary chain-of-custody.5,8,9
Accelerating Normalized Bookings and Hardware Replacements
In Q2 2026, 5-year normalized bookings expanded over 30%, Outpost and Lightpost rolling 12-month bookings reached ~$100M, and agencies canceled competitor contracts early to migrate to Axon, reinforcing management's $450M full-year FCFguidance.5
Under-Penetrated International Expansion Runway
Non-US revenue accounted for only $474.52M (17.07% of net sales) in FY2025, providing a multi-year global adoption runway across Commonwealth nations, Western Europe, and Latin America as agencies modernize evidence management.5,9
ハウスレコメンデーション
Despite Axon's formidable narrow platform moat in law enforcement cloud software, a valuation of 58.14x forward earnings prices in near-frictionless operational expansion and fails to reflect persistent stock-based compensationdilution ($634.23M in FY2025) and capital reinvestment requirements, warranting a Sell rating.4,8,9
企業概要
The key competitive factors in this product category include a device’s accuracy, effectiveness, reputation, safety, cost, ease of use, and exceptional customer experience. The design maturity of the TASER platform, as well as its development and sale of a multi-shot device, are also key competitive differentiators. AXON ENTERPRISE, INC. is aware of competitors providing competing CED products primarily outside of the United States. 1.Software and Services: AXON ENTERPRISE, INC. develops, manufacture and sell cloud-based Software-as-a-Service (“SaaS”) solutions that leverage AI and enable its customers to capture, securely store, manage, share and analyze video and other digital evidence. Its software offerings also support productivity and real-time operations.
Its offerings include Axon Evidence, Draft One, Axon Records, Axon Standards, Axon Fusus, and Axon Assistant, among others. In addition to subscription SaaS revenue, this segment includes non-recurring professional services revenue supporting implementation, configuration, and ongoing workflow integration, as well as revenue from certain on-premise software licenses.
§2 ベアケースEN
Under a compounded stress test where municipal law enforcement budget freezes collide with federal grant expirations, revenue growth decelerates from the modeled 33.29% baseline down to 12.0% annually. Concurrently, ongoing equity compensation exceeding 20% of revenue prevents GAAP operating margins from expanding beyond single digits, leaving diluted average shares to compound past 93 million. When combined with an equity re-rating that deflates Axon's forward P/E from 58.14x down toward peer benchmarks like L3Harris at 17.48x, enterprise valuation contracts severely. Under this stress scenario, intrinsic equity value compresses toward fundamental cash flow support, representing an asymmetric downside exposure against the current trading price of $413.35.
Under the Bear scenario, municipal law enforcement agencies encounter budget freezes and legislative delays that prolong hardware replacement intervals for TASER systems and body cameras. Concurrently, public safety anti-surveillance pushback and international sovereign data restrictions impede software expansion. Elevated stock-based compensation continues to dilute per-share equity value, while operating margins fail to achieve modeled operating leverage. As top-line growth decelerates, market valuation compresses toward aerospace and defense peer medians, causing severe capital impairment.
Axon's current valuation multiple of 58.14x forward P/E carries an extreme premium over defense peers such as L3Harris at 17.48x and TransDigm at 22.57x. If municipal procurement budget freezes delay hardware refresh cycles, compressing the valuation multiple below 20.0x toward defense peer averages over a 12-month horizon, fair value contracts by 28.5%.3,4
Signals saturation of Evidence.com attach within existing law enforcement agencies and failure of add-on software modules, disproving operating leverage assumptions.
Axon Enterprise Inc. has constructed an integrated public safety platform that combines non-lethal conducted energy devices, body-worn cameras, and the cloud-based Evidence.com ecosystem. In FY2025, consolidated revenue reached $2,779.54M, split between Connected Devices ($1,576.86M, 56.7% of sales) and Software and Sensors ($1,202.67M, 43.3% of sales). By deploying hardware devices on multi-year subscription bundles, Axon establishes an essential physical foothold in municipal police departments, subsequently capturing recurring software revenue through digital evidence storage, automated redaction, and records management.
The durability of Axon's competitive moat is rooted in the high switching costs of its Evidence.com software suite and the operational network effects of its expanding product ecosystem. Law enforcement agencies face steep technological, legal, and operational risks if they attempt to migrate terabytes of chain-of-custody evidentiary video to competing platforms. COO Josh Isner highlighted that law enforcement agencies are actively terminating competitor contracts early to adopt Axon's integrated suite. Furthermore, newer product lines such as Outpost and Lightpost generated ~$100M in rolling 12-month bookings, demonstrating Axon's capacity to cross-sell new hardware and software capabilities across its established customer relationships.
Against traditional aerospace and defense contractors, Axon maintains structural advantages. Defense primes such as L3Harris generate lower gross margins (LHX gross margin 25.48%) compared to Axon's consolidated gross margin of 59.65% ($1,658.13M gross profit in FY2025). Defense primes lack the municipal sales force, local government procurement relationships, and evidentiary compliance cloud software necessary to contest Axon's core law enforcement franchise. However, because current reported GAAP operating profitability remains negative (-$62.08M operating loss in FY2025) due to $634.23M in stock-based compensation, the moat rating is capped at Narrow (score 7.5) until sustained operating leverage produces GAAP returns above the 10.43% cost of capital.
経済的利益
Axon's reported economic profit is currently negative on a GAAP accounting basis due to substantial upfront operational spending. In FY2025, Axon recorded a GAAP operating loss of -$62.08M (-2.23% operating margin) on $2,779.54M of revenue, resulting in a trailing ROIC of -10.12%, which sits well below its computed WACC of 10.43% and moderate cost of equity of 10.21%. This drag is driven primarily by $634.23M in stock-based compensation alongside elevated R&D and SG&A expenses. However, normalized economic value creation is projected to inflect sharply as the house forecast models operating margins reaching 15.0% in FY2026 ($555.73M EBIT) and expanding to 24.5% by FY2030 ($1,992.06M EBIT) as recurring software subscription revenue scales.
7.5/ 10
Narrow
Sources of advantage
01High Customer Switching Costs in Digital Evidence Management — Evidence.com serves as the mission-critical cloud repository for video data, audit trails, and legal evidentiary chains of custody across public safety agencies. With Software and Sensors revenue reaching $1,202.67M in FY2025 (43.3% of total revenue), agency data integrations create extreme friction against migrating to rival point solutions, leading agencies to cancel competitor contracts early to consolidate onto Axon.Wide
02Proprietary Hardware Intellectual Property and Regulatory Compliance Intangibles — Axon holds dominant proprietary technology in conducted energy weapons with TASER 10, generating $1,576.86M in FY2025 Connected Devices revenue. The extensive patent portfolio, municipal training certifications, and policy standardization create severe barriers to entry for potential hardware substitutes.
モートに対する既知の脅威
脅威
深刻度
時間軸
緩和策
Public safety anti-surveillance pushback and strict data privacy regulations restricting video and biometric AI deployment.
medium
12-24 months
Axon engages ethics advisory boards, designs privacy-by-design redacting software, and structures strict client-governed data permissions.5
The highlighted cell is Fair value when every assumption sits at its base level ($219.27). Each row and column shows what Fair value becomes when one assumption moves.
FCFクリフ
Free cash flow to the firm stays positive in the first projected year at $290.4M after modeled reinvestment of $237.6M, with terminal value at 76.6% of enterprise value. A sudden drop in free cash flow is not projected unless capital spending relative to revenue, reinvestment, or gross margin resets materially.
Terminal valuation multiples reflect premium public safety software characteristics, discounted at the estimated cost of capital.
The Base case reflects the house forecast schedule where top-line expansion tracks consensus expectations through FY2026 and FY2027. Operating margins expand steadily from the FY2025 operating loss through FY2030 as Software and Sensors continues to outpace Connected Devices. Stock-based compensation expense is absorbed via modeled share count expansion, supporting the Base path target of $219.27.1,8,9
Revenue expansion accelerates significantly through FY2030, driven by rapid international market adoption and federal agency contracts.
Software and Sensors expands to represent the majority of net sales, elevating corporate substantially.
§7 決算デシジョンツリーEN
ビート
Upgrade the rating; Re-examine software attach momentum and free cash flow delivery, keeping a consistent defensive posture that avoids deploying incremental capital into an overextended valuation without a margin of safety.
トリガー: Quarterly revenue exceeding $1,102.52M (high end of consensus $1,059.62M mean), diluted EPS exceeding $2.84 (high end of consensus $2.27 mean), and multi-year normalized bookings growth accelerating above recent quarterly trends.5
Even if operational execution surpasses consensus expectations, forward valuation of 58.14x P/E already prices in aggressive multi-year compounding, leaving the stock trading at a substantial premium to Fair value $219.27. A beat reinforces operational durability but does not provide an attractive margin of safety.
トリガー: Quarterly revenue matching consensus mean of $1,059.62M, diluted EPS of approximately $2.27, and normalized bookings expansion consistent with recent commentary.5
In-line results validate the forecast trajectory but provide no valuation catalyst to overcome the severe valuation gap against Fair value $219.27.
ミス
Exit the position; Close out remaining holdings and eliminate exposure to avoid compounding downside toward fundamental cash flow support.
With the stock trading at 58.14x forward P/E, any growth slowdown or margin shortfall triggers violent multiple compression toward mature defense contractor averages (LHX 17.48x, NOC 15.70x).
利益の質
Axon's earnings quality is characterized by a significant disparity between reported GAAP results and provider-adjusted operating figures. In FY2025, Axon reported GAAP net income of $124.66M and diluted EPS of $1.51, yet GAAP operating income was negative at -$62.08M. This discrepancy is driven by $634.23M in stock-based compensation, which is added back in adjusted figures, alongside discrete windfall tax benefits on equity vesting. Furthermore, high deferred revenue balances from upfront multi-year contracts provide revenue predictability but require careful reconciliation against actual cash collections and inventory commitments.8
Operating cash flow was $211.34M in FY2025, supporting free cash flow of $75.08M after deducting $136.26M in capex. Cash flow conversion was dampened by working capital absorption and inventory investments for the TASER 10 ramp. In Q2 2026, capex subsided to $21.05M ($22.95M YTD), aligning with CFO Brittany Bagley's affirmation of strong full-year free cash flow line of sight toward $450M guidance.5,6,7,8
資本配分
Axon allocates 100% of capital toward internal organic expansion, product development, and targeted capability acquisitions, paying zero dividends. In FY2025, reached $136.26M alongside heavy R&D expensing, while totaled $634.23M (22.82% of ), which diluted average shares to 82.37M. Strategic acquisitions including Carbyne and Prepared were integrated directly into Axon 911 to consolidate dispatch software capabilities, reinforcing platform lock-in.
Axon's capital productivity reflects a classic hyper-growth transition. The front-loaded manufacturing investments ($136.26M capex in FY2025) and high equity incentives expand the customer base and software ecosystem, after which incremental recurring subscription revenues flow through at high gross margins (59.65% in FY2025), driving substantial economic value creation.
In FY2025, Axon generated an accounting operating loss of -$62.08M, resulting in a trailing ROIC of -10.12%, well below the computed WACC of 10.43%. This negative spread is temporary, caused by front-loaded R&D ($684.31M) and $634.23M in stock-based compensation. As EBIT margins expand from 15.0% in FY2026 to 24.5% by FY2030 in the house forecast schedule, forward ROIC improves to exceed WACC by more than 12 percentage points.
Axon Enterprise Inc. (AXON) trades at 58.1x forward earnings against a peer median of 17.5x. Its EV/EBITDA of 210.4x compares with a peer median of 13.4x. The comparison uses 4 peers: L3Harris Technologies Inc., Rocket Lab Corporation, TransDigm Group Incorporated and Northrop Grumman Corporation, as of 2026-10-03.
§10 業界とサイクルEN
サイクルフェーズ
Peak
Axon's capital expenditure expanded from $59.64M in FY2023 to $78.79M in FY2024 and peaked at $136.26M in FY2025 (4.90% of revenue and 1.64x D&A of $83.16M) to establish automated manufacturing lines for TASER 10. In Q2 2026, capex subsided to $21.05M ($22.95M YTD), while aerospace and defense industry benchmarks reflect normalized capex-to-revenue of 0.8% and capex-to-depreciation of 0.95x.6,8
強気サイクル
Accelerating federal agency procurement, international modernization programs across Tier-1 democracies, and rapid adoption of AI-enabled records management and real-time operations (Outpost/Lightpost bookings reaching ~$100M), driving 30%+ top-line growth.
弱気サイクル
Municipal tax revenue contraction, local budget reallocation away from policing hardware, delays in federal grant disbursements, and public pushback against surveillance technologies.
長期トレンド
トレンド
影響
備考
Digital Transformation and Cloud Evidence Consolidation in Public Safety
positive
Law enforcement agencies are shifting from fragmented on-premises storage to secure cloud platforms, accelerating Software and Sensors revenue to $1,202.67M in FY2025 and driving 5-year normalized bookings growth over 30%.
Shift Toward Non-Lethal Force and Evidentiary Accountability
positive
ポジショニング
Axon occupies an entrenched, quasi-monopolistic position across municipal law enforcement in the United States, which generated $2,305.01M (82.93% of sales) in FY2025. Its hardware installed base in TASER devices and body cameras locks agencies into long-term Evidence.com cloud subscriptions, creating high barriers that traditional defense contractors like L3Harris and Northrop Grumman cannot overcome.3,9
§11 ポジション管理EN
サイジング
0%
Under the committee's Sell rating, the recommended position allocation is 0%. Axon trades at $413.35, representing an 88.5% premium over the synthesized fair value midpoint of $219.27 and a forward P/E of 58.14x. High conviction in this underweight stance is driven by the stark disconnect between reported GAAP operating losses (-$62.08M in FY2025), heavy stock-based compensationdilution ($634.23M in FY2025), and excessive market valuation multiples relative to mature defense contractors.3,4,8
リスク
Active risk management requires monitoring municipal budget trends, tracking federal grant renewal cycles, and scrutinizing quarterly filings for share countdilution. Axon's raw beta of 1.3826 and adjusted beta of 1.2012 denote elevated equity volatility. Portfolios with institutional mandate constraints should hedge long technology exposure with aerospace and defense peers (such as L3Harris, NOC, or TDG) to insulate capital from market-wide valuation de-rating.
エントリートランシェ
レベル
アクション
理由
$219.27
Fundamental valuation checkpoint to assess whether operating margin expansion has materialized.
Represents the house fair value midpoint where risk-adjusted expected return transitions to neutral.
$165.18
Secondary re-evaluation point for selective long re-entry under conservative multiple assumptions.
エグジットトランシェ
レベル
アクション
$413.35
Liquidate existing long holdings at current market levels to capture substantial market premiums.
$462.33
Exhaustive exit of any remaining legacy holdings if short-term speculative momentum pushes price toward the 5-year undiscounted base target.
Reconfirm sell posture and lower normalized terminal margin assumptions in valuation models.9
§12 投資家の視点EN
Value / Fundamental Investor
Avoid
Trading at 58.14x forward earnings and an 88.51% premium to fair value ($219.27), Axon offers negative implied return (-46.95%) and zero margin of safety against GAAP operating losses (-$62.08M in FY2025).4,8
Growth / Momentum Investor
Avoid
Although top-line growth and bookings remain robust (>30% 5-year normalized bookings), heavy stock-based compensation of $634.23M (22.82% of revenue) significantly dilutes per-share compounding, while the current multiple leaves severe downside in any procurement slowdown.5,8
Income / Total Return Investor
Avoid
Axon pays zero dividends and reinvests capital aggressively into manufacturing automation ($136.26M capex in FY2025), delivering compressed free cash flow of $75.08M that fails to support total return at a $413.35 market price.4,7,8
§14 最終推奨EN
アクション
売り
At $413.35 as of October 2, 2026, the market trades at 58.14x forward earnings, discounting 43.60% long-term earnings expansion. This pricing leaves no buffer for the reality of FY2025 GAAP operating losses (-$62.08M), high stock-based compensationdilution ($634.23M), or capital reinvestment burdens ($136.26M capex).4,8
While Axon maintains a defensible narrow competitive moat powered by Evidence.com customer switching costs and >30% 5-year normalized bookings growth, the risk-reward skew is highly unfavorable. Investors should take profits or reduce exposure until share prices converge toward intrinsic value.
§15Your notes
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
Private notes
Visible only to you. Synced to this device.
0 chars
Sources
The records this analysis drew on, as they stood when it was run.
Analyst consensusData as of 2026-10-03 · Published 2026-10-03 · Provider-adjusted · cited for 1 figuresCited in ベアケース, シナリオ
Macro and cost of capitalData as of 2026-10-03 · Published 2026-10-03 · cited for 4 figuresCited in 競争優位性, 財務履歴, ポジション管理
Earnings call transcript2026Q2 earnings callData as of 2026-06-30 · Published 2026-08-05 · cited for 8 figuresCited in 競争優位性, エグゼクティブサマリー, 財務履歴, ベアケース, 業界とサイクル, 決算デシジョンツリー, 投資家の視点, 最終推奨, ポジション管理Licensed source: named and dated here, not linked.
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
Severe Public Safety Budget Contraction and Growth Stagnation
The house forecast models 33.29% revenue growth in FY2026 and 29.33% in FY2027 ($4,791.83M consensus). If federal grant programs face cuts and municipal tax receipts decline, causing sales growth across Connected Devices ($1,576.86M in FY2025) and Software ($1,202.67M in FY2025) to drop below 15.0% over a 36-month horizon, fair value contracts by 41.0%.1,9
FV impact
-13.6%
Revenue and EPS growth 10 points lower for five years
Indicates permanent structural capital intensity in manufacturing automation rather than a temporary investment cycle, depressing free cash flow conversion.
Indicates competitive discounting or commoditization of hardware and video capture from defense or commercial competitors, eroding platform pricing power.
03Integrated Public Safety Workflow Software Network Effects — Axon's software platform connects dispatch, field operations, in-car cameras, drones, and records management, enhanced by the integration of Carbyne and Prepared into Axon 911. As regional agencies interconnect evidence-sharing workflows, ecosystem utility expands, supporting 5-year normalized bookings growth exceeding 30%.Moderate
Transitioning equity incentive plans toward operating cash flow performance thresholds and leveraging scale to moderate share dilution toward 1.5% annually.
Sovereign procurement protectionism and local cloud residency mandates slowing international market penetration.
medium
24-36 months
Establishing localized data center partnerships with major cloud providers and tailoring non-lethal weapon specifications to regional legal frameworks.9
Discounted forecast-period cash flows ($29.57) plus discounted terminal value ($96.67) minus signed per current share ($1.28) equals the $125 lens value shown above. Negative net debt is , so subtracting it raises value.
Terminal valuation multiples hold at an elevated premium to broader market averages.
Under the Bull scenario, Axon accelerates adoption across federal agencies and international law enforcement jurisdictions, expanding non-US revenue as a share of consolidated sales. Accelerated attach of Evidence.com add-on modules, including automated draft reporting and real-time operations, lifts Software and Sensors revenue to become the primary driver of top-line scale. Gross margins expand as cloud software mix increases, while operating leverage drives operating margins higher. Free cash flow conversion expands rapidly as capital expenditures normalize, supporting robust earnings compounding toward the Bull path target of $345.49.
現在FY2025 capex peaked at $136.26M; Q2 2026 capex moderated to $21.05M with full-year free cash flowguidance affirmed.
重要な理由
Validates whether the conducted energy device manufacturing tooling cycle has peaked, allowing cash generation to reach management guidance.
04
指標:
International Revenue Expansion and Market Penetration
現在Non-US revenue generated $474.52M in FY2025, accounting for 17.07% of consolidated sales.
重要な理由
International adoption provides the long-term addressable market expansion necessary to sustain robust top-line growth beyond the mature domestic law enforcement base.
05
指標:
Gross Margin Durability vs Aerospace and Defense Competitors
現在FY2025 gross margin was 59.65% ($1,658.13M gross profit), compared to peer L3Harris at 25.48%.
重要な理由
Protects the software-enabled pricing power that justifies Axon's valuation multiple premium over hardware-centric defense primes.
Software and Sensors revenue reached $1,202.67M in FY2025 (43.27% of sales), supporting consolidated gross margin of 59.65% with $1,658.13M in gross profit.
As high-margin SaaS subscriptions grow faster than hardware shipments, corporate gross margins are insulated from hardware cost inflation and defense prime discounting.
Stock-based compensation of $634.23M in FY2025 represented 22.82% of revenue and drove a GAAP operating loss of -$62.08M, while diluted shares expanded to 82.37M.
Investors relying on provider-adjusted metrics fail to account for real economic dilution, which dampens per-share compounding unless share growth is explicitly modeled.
Manufacturing Tooling Buildout Has Passed Its Peak Capital Intensity
Capex jumped from $59.64M in FY2023 to $136.26M in FY2025, but moderated to $21.05M in Q2 2026 ($22.95M YTD).
Societal demand for de-escalation tools and transparent policing drives widespread adoption of TASER 10 and next-generation body-worn cameras, supporting Connected Devices revenue of $1,576.86M in FY2025.
Heightened Scrutiny on Public Surveillance and Biometric AI
negative
Anti-surveillance movements and regulatory scrutiny regarding facial recognition and automated officer tracking introduce friction into municipal procurement approvals and product deployments.
